Berge Terence M 4

Accession 0001127602-21-009281

CIK 0000816956other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 7:08 PM ET

Size

30.6 KB

Accession

0001127602-21-009281

Insider Transaction Report

Form 4

Period: 2021-03-01

CONMED CORPCNMD

Berge Terence M

VP Corp. Treasurer

Transactions

Exercise/Conversion
Options To Purchase Common Stock
2021-03-01−2,700→ 5,400 total
Exercise: $59.96Exp: 2028-03-01→ Common Stock (2,700 underlying)
Award
Options To Purchase Common Stock
2021-03-01+12,000→ 12,000 total
Exercise: $122.55Exp: 2031-03-01→ Common Stock (12,000 underlying)
Exercise/Conversion
Common Stock
2021-03-01$39.87/sh+3,860$153,898→ 4,864 total
Sale
Common Stock
2021-03-01$122.77/sh−3,860$473,903→ 1,004 total
Exercise/Conversion
Common Stock
2021-03-01$41.93/sh+2,800$117,404→ 3,804 total
Sale
Common Stock
2021-03-01$122.53/sh−2,800$343,075→ 1,004 total
Exercise/Conversion
Common Stock
2021-03-01$59.96/sh+2,700$161,892→ 3,704 total
Sale
Common Stock
2021-03-01$122.50/sh−2,700$330,750→ 1,004 total
Exercise/Conversion
Common Stock
2021-03-01$78.76/sh+5,400$425,304→ 6,404 total
Sale
Common Stock
2021-03-01$122.50/sh−5,400$661,500→ 1,004 total
Exercise/Conversion
Common Stock
2021-03-01$97.69/sh+2,550$249,110→ 3,554 total
Sale
Common Stock
2021-03-01$122.50/sh−2,550$312,375→ 1,004 total
Exercise/Conversion
Options To Purchase Common Stock
2021-03-01−3,860→ 0 total
Exercise: $39.87Exp: 2026-03-01→ Common Stock (3,860 underlying)
Exercise/Conversion
Options To Purchase Common Stock
2021-03-01−2,800→ 2,800 total
Exercise: $41.93Exp: 2031-03-01→ Common Stock (2,800 underlying)
Exercise/Conversion
Options To Purchase Common Stock
2021-03-01−5,400→ 8,100 total
Exercise: $78.76Exp: 2029-03-01→ Common Stock (5,400 underlying)
Exercise/Conversion
Options To Purchase Common Stock
2021-03-01−2,550→ 10,200 total
Exercise: $97.69Exp: 2030-03-02→ Common Stock (2,550 underlying)

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.66 to $122.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $122.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
[F3]The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
[F4]The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CONMED CORP

CIK 0000816956

→

Entity typeother

Related Parties

filerCIK 0001635424

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 7:08 PM ET
Size: 30.6 KB

View on SEC.gov